IRIS Accounts Production v23.3.1.45 04767019 director 1.6.22 31.5.23 31.5.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh047670192022-05-31047670192023-05-31047670192022-06-012023-05-31047670192021-05-31047670192021-06-012022-05-31047670192022-05-3104767019ns10:Originalns15:EnglandWales2022-06-012023-05-3104767019ns14:PoundSterlingns10:Original2022-06-012023-05-3104767019ns10:Originalns10:Director12022-06-012023-05-3104767019ns10:Original2022-06-012023-05-3104767019ns10:Original2023-05-3104767019ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3104767019ns10:Originalns10:SmallEntities2022-06-012023-05-3104767019ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3104767019ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3104767019ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3104767019ns10:Originalns10:FullAccounts2022-06-012023-05-3104767019ns10:Original12022-06-012023-05-3104767019ns10:Original2022-05-3104767019ns10:Originalns5:CurrentFinancialInstruments2023-05-3104767019ns10:Originalns5:CurrentFinancialInstruments2022-05-3104767019ns10:Originalns5:Non-currentFinancialInstruments2023-05-3104767019ns10:Originalns5:Non-currentFinancialInstruments2022-05-3104767019ns5:ShareCapitalns10:Original2023-05-3104767019ns5:ShareCapitalns10:Original2022-05-3104767019ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3104767019ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3104767019ns10:Originalns10:RegisteredOffice2022-06-012023-05-3104767019ns10:Original12022-06-012023-05-3104767019ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-06-012023-05-3104767019ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2022-06-012023-05-3104767019ns10:Originalns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-06-012023-05-3104767019ns10:Originalns5:FurnitureFittings2022-06-012023-05-3104767019ns10:Originalns5:ComputerEquipment2022-06-012023-05-3104767019ns10:Original2021-06-012022-05-3104767019ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2022-05-3104767019ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2023-05-3104767019ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2022-05-3104767019ns10:Originalns5:LandBuildings2022-05-3104767019ns10:Originalns5:FurnitureFittings2022-05-3104767019ns10:Originalns5:ComputerEquipment2022-05-3104767019ns10:Original2022-05-3104767019ns10:Originalns5:LandBuildings2022-06-012023-05-3104767019ns10:Originalns5:LandBuildings2023-05-3104767019ns10:Originalns5:FurnitureFittings2023-05-3104767019ns10:Originalns5:ComputerEquipment2023-05-3104767019ns10:Originalns5:LandBuildings2022-05-3104767019ns10:Originalns5:FurnitureFittings2022-05-3104767019ns10:Originalns5:ComputerEquipment2022-05-3104767019ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3104767019ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3104767019ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-05-3104767019ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-05-3104767019ns5:Securedns10:Original2023-05-3104767019ns5:Securedns10:Original2022-05-3104767019ns10:Original1ns10:Director12022-05-3104767019ns10:Original1ns10:Director12021-05-3104767019ns10:Original1ns10:Director12022-06-012023-05-3104767019ns10:Original1ns10:Director12021-06-012022-05-3104767019ns10:Original1ns10:Director12023-05-3104767019ns10:Original1ns10:Director12022-05-31
REGISTERED NUMBER: 04767019 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 May 2023

for

B P Clinic Limited

B P Clinic Limited (Registered number: 04767019)

Contents of the Financial Statements
for the Year Ended 31 May 2023










Page

Balance Sheet 1

Notes to the Financial Statements 3


B P Clinic Limited (Registered number: 04767019)

Balance Sheet
31 May 2023

31.5.23 31.5.22
Notes £ £
Fixed assets
Intangible assets 5 31,050 31,050
Tangible assets 6 1,281,210 1,981,966
Investments 7 - 147,145
1,312,260 2,160,161

Current assets
Stocks 962 962
Debtors 8 260,500 6,040
Cash at bank 232,073 280,411
493,535 287,413
Creditors
Amounts falling due within one year 9 (363,032 ) (522,544 )
Net current assets/(liabilities) 130,503 (235,131 )
Total assets less current liabilities 1,442,763 1,925,030

Creditors
Amounts falling due after more than one
year

10

(111,994

)

(727,611

)

Provisions for liabilities (17,225 ) (9,126 )
Net assets 1,313,544 1,188,293

B P Clinic Limited (Registered number: 04767019)

Balance Sheet - continued
31 May 2023

31.5.23 31.5.22
Notes £ £
Capital and reserves
Called up share capital 203 203
Retained earnings 1,313,341 1,188,090
1,313,544 1,188,293

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 February 2024 and were signed by:





Dr B Beigi - Director


B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements
for the Year Ended 31 May 2023


1. Statutory information

B P Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04767019

Registered office: 22-26 King Street
King's Lynn
Norfolk
PE30 1HJ

2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention or historic cost modified by revaluation of financial assets and financial liabilities held at fair value through profit and loss, except for the financial instruments that are measured at their fair values at the end of each reporting period, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.

The presentation currency of the financial statements is the Pound Sterling (£).

The principal accounting policies adopted are set out below. All accounting policies have been applied
consistently, other than where new policies have been adopted.

Going Concern
The directors believe that the company is well placed to manage its financial risks successfully and have
reasonable expectation that it has adequate resources to continue in operational existence for the foreseeable future and have therefore accordingly prepared these financial statements on a going concern basis.

B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


3. Accounting policies - continued

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

(i) Useful economic lives of tangible assets

The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful
economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancements, future investments, economic utilisation and the physical condition of the assets. See notes to the accounts for the carrying amount of tangible assets and the useful economic lives for each class of assets.

(ii) Taxation

The company establishes provisions based on reasonable estimates, for possible consequences of audits by the tax authorities. The amount of such provisions is based on various factors, such as experience with the
previous tax audits and differing interpretations of tax regulations by the taxable entity and the responsible tax
authority.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts and rebates on the supply of medical procedures.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Freehold property - No depreciation
Fixtures and fittings - 25% p.a. reducing balance
Computer equipment - 25% p.a. reducing balance

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated
depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair
value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being
estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


3. Accounting policies - continued

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


3. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the
obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial
position and the amount of the provision as an expense.

Provisions are initially measured at the best estimate of the amount required to settle the obligation at the
reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best
estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts
previously recognised are recognised in profit or loss unless the provision was originally recognised as part of
the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

4. Employees and directors

The average number of employees during the year was 4 (2022 - 5 ) .

5. Intangible fixed assets
Patents and
licences
£
Cost
At 1 June 2022
and 31 May 2023 31,050
Net book value
At 31 May 2023 31,050
At 31 May 2022 31,050

B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


6. Tangible fixed assets
Fixtures
Freehold and Computer
property fittings equipment Totals
£ £ £ £
Cost
At 1 June 2022 1,977,340 191,339 50,422 2,219,101
Additions - 10,825 4,076 14,901
Disposals (735,305 ) - - (735,305 )
At 31 May 2023 1,242,035 202,164 54,498 1,498,697
Depreciation
At 1 June 2022 31,879 168,241 37,015 237,135
Charge for year - 8,281 3,929 12,210
Eliminated on disposal (31,858 ) - - (31,858 )
At 31 May 2023 21 176,522 40,944 217,487
Net book value
At 31 May 2023 1,242,014 25,642 13,554 1,281,210
At 31 May 2022 1,945,461 23,098 13,407 1,981,966

7. Fixed asset investments

Investments (neither listed nor unlisted) were as follows:
31.5.23 31.5.22
£ £
Addition 147,145 147,145
Disposal (147,145 ) -
- 147,145

8. Debtors: amounts falling due within one year
31.5.23 31.5.22
£ £
Other debtors 260,500 6,040

9. Creditors: amounts falling due within one year
31.5.23 31.5.22
£ £
Bank loans and overdrafts 20,078 36,338
Trade creditors 1,227 2,877
Taxation and social security 46,822 40,473
Other creditors 294,905 442,856
363,032 522,544

B P Clinic Limited (Registered number: 04767019)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


10. Creditors: amounts falling due after more than one year
31.5.23 31.5.22
£ £
Bank loans 111,994 727,611

Amounts falling due in more than five years:

Repayable otherwise than by instalments
Bank loans more 5 yrs non-inst - 503,074

Repayable by instalments
Bank loans more 5 yr by instal 31,681 100,851

11. Secured debts

The following secured debts are included within creditors:

31.5.23 31.5.22
£ £
Bank loans 132,072 -

Security has been provided in respect of the bank loan, by way of a fixed and floating debenture charge in favour of National Westminster Bank PLC over all the assets of the company.

12. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 31 May 2023 and 31 May 2022:

31.5.23 31.5.22
£ £
Dr B Beigi
Balance outstanding at start of year (13,255 ) (50,733 )
Amounts advanced 359,518 187,712
Amounts repaid (238,948 ) (150,234 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 107,315 (13,255 )

The directors balance was repaid within 9 months of the year end and interest was charged at the official rate.

13. Related party disclosures

No transactions were undertaken with directors or related parties such as are required to be disclosed under
the Financial Reporting Standard 102, Section 1A.